Cargando…

Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary)()

Detalles Bibliográficos
Autor principal:	Elborn, J Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461043/ https://www.ncbi.nlm.nih.gov/pubmed/34565704 http://dx.doi.org/10.1016/j.jcf.2021.09.003

Ejemplares similares

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Protein biomarkers in cystic fibrosis research: where next?
por: Pattison, Sally H, et al.
Publicado: (2010)

Organisms isolated from adults with Cystic Fibrosis
por: McManus, Terence E, et al.
Publicado: (2004)

Financial impacts of the COVID-19 pandemic on cystic fibrosis care: Lessons for the future (Commentary) A.L. Stephenson()
por: Stephenson, Anne L.
Publicado: (2021)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()
por: Franciosi, Alessandro N, et al.
Publicado: (2021)

1078. Expectations and Attitudes Toward Antimicrobial Stewardship Among Cystic Fibrosis Care Providers
por: Bullington, Wendy, et al.
Publicado: (2019)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Infection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosis
por: Moore, John E, et al.
Publicado: (2004)

Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future()
por: Sawicki, Gregory S., et al.
Publicado: (2021)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis.
por: Elborn, J. S., et al.
Publicado: (1992)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Advances in Cystic Fibrosis Research in Qatar: A Commentary
por: Hammoudeh, Samer, et al.
Publicado: (2023)

Shortened Lung Clearance Index is a repeatable and sensitive test in children and adults with cystic fibrosis
por: Hannon, David, et al.
Publicado: (2014)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa
por: Bertelsen, Anne, et al.
Publicado: (2020)

Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
por: Xu, Jiru, et al.
Publicado: (2004)

New strategies of physical activity assessment in cystic fibrosis: a pilot study
por: Savi, Daniela, et al.
Publicado: (2020)

Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study
por: Tiddens, Harm A. W. M., et al.
Publicado: (2020)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
por: Shteinberg, Michal, et al.
Publicado: (2017)

Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care()
por: Sabadosa, Kathryn A., et al.
Publicado: (2021)

Scale-up of Digital Innovations in Health Care: Expert Commentary on Enablers and Barriers
por: Schlieter, Hannes, et al.
Publicado: (2022)

Managing Cystic Fibrosis in Polish Healthcare
por: Rachel, Marta, et al.
Publicado: (2020)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
por: Bradley, Judy M., et al.
Publicado: (2014)

Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions
por: McCaughey, Gerard, et al.
Publicado: (2013)

Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting
por: Albon, Dana, et al.
Publicado: (2022)

Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials
por: Dobra, Rebecca Anne, et al.
Publicado: (2021)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
por: Denford, Sarah, et al.
Publicado: (2020)

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW
por: Gramegna, Andrea, et al.
Publicado: (2018)

Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary)()
por: Ranganathan, Sarath C.
Publicado: (2021)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”
por: Hirche, T. O., et al.
Publicado: (2015)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
por: Hirche, T. O., et al.
Publicado: (2014)

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
por: Elborn, JS, et al.
Publicado: (2016)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

Lessons learned from metabolomics in cystic fibrosis
por: Muhlebach, Marianne S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bjcc113i3ps1jgjpb790qba48g